Gut microbial communities in chronic rhinosinusitis patients in response to 1,8-Cineol treatment
Our data recommend 1,8-Cineol as a valuable addition to the current standard treatment of inflammatory diseases, without running the risk of profound changes of the gut microbial community.
Authors
- Zuzana Penxová (ORCID: https://orcid.org/0000-0001-5673-3498)
- Sven Künzel (ORCID: https://orcid.org/0000-0003-4992-5963)
- Mariia Lupatsii (ORCID: https://orcid.org/0000-0003-1373-8621)
- Barbara Wollenberg (ORCID: https://orcid.org/0000-0002-3062-459X)
- Anke Leichtle (ORCID: https://orcid.org/0000-0001-8067-4299)
- Ralph Pries (ORCID: https://orcid.org/0000-0003-4056-0654)
- Stephanie Jeschke
- Simon Graspeuntner (ORCID: https://orcid.org/0000-0002-2546-2223)
- Mathias Heidemann
- Michael Ploch
- Karl‐Ludwig Bruchhage
Institutions
- Klosterfrau Healthcare Group (Germany) (DE)
- Max Planck Institute for Evolutionary Biology (DE)
- Technical University of Munich (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Current Research in Microbial Sciences
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.crmicr.2025.100442
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00